Dr. Anthony W. Tolcher is a Medical Oncologist who specializes in Medical Oncology, and is certified by the American Board of Internal Medicine. He practices at Texas Oncology-San Antonio Babcock Next Oncology located at 2829 Babcock Road, Suite 300, San Antonio, TX 78229, and can be reached at 210-580-9500.

Dr. Tolcher's research interests include the development of new anticancer agents through Phase I and clinical pharmacology clinical trials, as well as exploring molecular genetic targets for cancer therapy. He has a significant experience in the field of medical oncology, having served as the Director of Clinical Research at South Texas Accelerated Research Therapeutics from April 2007 to January 2018, and as the Director of Clinical Research and Associate Director at the Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio, San Antonio, TX from September 2003 to April 2007.

Dr. Tolcher played a significant role in the founding of the San Antonio 1000 Cancer Genome Project, which aims to accelerate the development of a cure for cancer by conducting whole genome sequencing of cancerous and normal tissues. He has written many publications and is a reviewer for several peer-reviewed publications.

Dr. Tolcher's education includes a Fellowship in Research from the National Cancer Institute, Bethesda, MD, Fellowship in Oncology from The University of British Columbia Vancouver, BC, Canada, Residency in Internal Medicine from University of Toronto, Toronto, Ontario, and Medical Doctorate from The University of British Columbia, Vancouver, BC, Canada. Dr. Tolcher is a member of several professional organizations, including American College of Physicians, American Society of Clinical Oncology and Royal College of Physicians and Surgeons of Canada.